1 Since then, newer, more effective GLP-1 agonists have come to market for both diabetes and weight loss
The growth in the historic period can be attributed to rising prevalence of type 2 diabetes, increased awareness of glycemic control therapies, strong clinical efficacy versus traditional antidiabetics, physician preference for incretin-based therapies, favorable reimbursement in developed markets
So, when drugs like Ozempic, Wegovy, and their GLP-1 agonist cousins exploded onto the scene, promising significant weight loss, it's no surprise ears perked up in the peloton
Now, socialising for me is more fitness-related activities or talking and connecting more than eating or drinking. Adds Mehta, That one glass of wine is a rarity now. In a biological sense too, theres a singularity in Indias diabetes-obesity continuum, and most doctors say GLP-1 drugs are unlikely to crack this complexity
Blocking the receptors in the arcuate nucleus or in the nodose ganglion does not block the effect, she said, so we really need to focus on these hindbrain NST [nucleus of the solitary tract] neurons. To address the issue of whether GLP-1R agonists applied systemically directly access central GLP-1 receptors, Rinaman showed some images of brain regions with GLP-1 receptors and the axons of GLP-1 neurons labeled in different colors (Farkas et al., 2021)